Plasma high-density lipoprotein cholesterol but not apolipoprotein A-I is a good correlate of the visceral obesity-insulin resistance dyslipidemic syndrome

Metabolism: Clinical and Experimental

Volumn 45, Issue 7, 1996, Pages 882-888

  Couillard, Charles ^c   Lamarche, Benoît ^a   Tchernof, André ^c   Prud'homme, Denis ^c   Tremblay, Angelo ^c   Bouchard, Claude ^c   Moorjani, Sital ^c   Nadeau, André ^c   Lupien, Paul J ^c   Després, Jean Pierre ^b  

^a Natl Hlth R and D Program   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY FAT; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; CORONARY RISK; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; SYNDROME DELINEATION;

EID: 15844418451     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(96)90164-X     Document Type: Article

References (48)

1. Larsson B, Björntorp P, Tibblin G: The health consequences of moderate obesity. Int J Obes 5:97-116, 1988
2. Kissebah AH, Vydelingum N, Murray R, et al: Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 54:254-260, 1982
3. Krotkiewski M, Björntorp P, Sjöström L, et al: Impact of obesity on metabolism in men and women: Importance of adipose tissue distribution. J Clin Invest 72:1150-1162, 1983
4. Kalkhoff RK, Hartz AH, Rupley D, et al: Relationship of body fat distribution to blood pressure, carbohydrate tolerance, and plasma lipids in healthy obese women. J Lab Clin Med 102:621-627, 1983
5. Evans DJ, Hoffman RG, Kalkhoff RK, et al: Relationship of body fat topography to insulin sensitivity and metabolic profiles in premenopausal obese women. Metabolism 33:68-75, 1984
6. Després JP, Allard C, Tremblay A, et al: Evidence for a regional component of body fatness in the association with serum lipids in men and women. Metabolism 34:967-973, 1985
7. Haffner SM, Stern MP, Hazuda HP, et al: Do upper-body and centralized adiposity measure different aspects of regional body-fat distribution? Relationship to non insulin-dependent diabetes mellitus, lipids, and lipoproteins. Diabetes 36:43-51, 1987
8. Després JP, Tremblay A, Pérusse L, et al: Abdominal adipose tissue and serum HDL-cholesterol: Association independent from obesity and serum triglyceride concentration. Int J Obes 12:1-13, 1988
9. Anderson AJ, Sobocinski KA, Freedman DS, et al: Body fat distribution, plasma lipids and lipoproteins. Arteriosclerosis 8:88-94, 1988
10. Després JP, Ferland M, Moorjani S, et al: Role of hepatictriglyceride lipase activity in the association between intraabdominal fat and plasma HDL-cholesterol in obese women. Arteriosclerosis 9:485-492, 1989
11. Pouliot MC, Després JP, Nadeau A, et al: Visceral obesity in men - Associations with glucose tolerance, plasma insulin, and lipoprotein levels. Diabetes 41:826-834, 1992
12. Zavaroni I, Bonini L, Fantuzzi M, et al: Hyperinsulinemia, obesity and syndrome X. J Intern Med 235:51-56, 1994
13. Zavaroni I, Bonora E, Pagliara M, et al: Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 320:702-706, 1989
14. Zavaroni I, Dall'Aglio E, Bonora E, et al: Evidence that multiple risk factors for coronary artery disease exist in persons with abnormal glucose tolerance. Am J Med 83:609-612, 1987
15. Després JP: Obesity and lipid metabolism: Relevance of body fat distribution. Curr Opin Lipidol 2:5-15, 1991
16. Després JP: Lipoprotein metabolism in visceral obesity. Int J Obes 15:45-52, 1991
17. Björntorp P: Hazards in subgroups of human obesity. Eur J Clin Invest 14:239-241, 1984
18. Després JP, Tremblay A, Thériault G, et al: Relationship between body fatness, adipose tissue distribution and blood pressure in men and women. J Clin Epidemiol 41:889-897, 1988
19. 3 cholesterol, apo A-I and apo A-II, and the risk of myocardial infarction. Circulation 85:22-29, 1992
20. Stampfer MJ, Sacks FM, Salvini S, et al: A prospective study of cholesterol, apolipoproteins and the risk of myocardial infarction. N Engl J Med 325:373-381, 1991
21. Miller NE: Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Am Heart J 113:589-597, 1987
22. Kwiterovich PO, Sniderman AD: Atherosclerosis and apoproteins B and A-I. Prev Med 12:815-834, 1983
23. Maciejko JJ, Holmes DR, Kottke BA, et al: Apolipoprotein A-I as a marker of angiographically assessed coronary artery disease. N Engl J Med 309:385-389, 1983
24. DeBacker G, Rosseneu M, Deslypere JP: Discriminative value of lipids and apoproteins in coronary heart disease. Atherosclerosis 42:197-203, 1982
25. Reisen WF, Mordasini R, Salzmann C, et al: Apoproteins and lipids as discriminators of severity of coronary heart disease. Atherosclerosis 37:157-162, 1980
26. Puchois P, Kandoussi A, Fieret P, et al: Apolipoprotein A-I lipoproteins in coronary artery disease. Atherosclerosis 68:35-40, 1987
27. Lohman T, Roche A, Martorel R (eds): The Airlie (VA) Consensus Conference, in Standardization of Anthropometric Measurements. Champaign, IL, Human Kinetics, 1988, pp 39-80
28. Behnke AR, Wilmore JH: Evaluation and regulation of body build and composition. Engelwood Cliffs, CA, Prentice-Hall, 1974, pp 20-37
29. Siri WE: The gross composition of the body. Adv Biol Med Phys 4:239-280, 1956
30. Ferland M, Després JP, Tremblay A, et al: Assessment of adipose tissue distribution by computed tomography in obese women: Association with body density and anthropometric measurements. Br J Nutr 61:139-148, 1986
31. Després JP, Prud'homme D, Pouliot MC, et al: Estimation of deep abdominal adipose-tissue accumulation from simple anthropometric measurements in men. Am J Clin Nutr 54:471-477, 1991
32. Kvist H, Tylen U, Sjöström L: Adipose tissue volume determinations in women by computed tomography: Technical considerations. Int J Obes 10:53-67, 1986
33. Richterich R, Dauwalder H: Zur bestimmung der plasmaglukosekonzentration mit der hexokinase-glucose-6-phosphat-dehydrogenase-methode. Schweiz Med Wochenschr 101:615-618, 1971
34. Desbuquois B, Aurbach GD: Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J Clin Endocrinol Metab 37:732-738, 1971
35. Moorjani S, Dupont A, Labrie F, et al: Increase in plasma high-density lipoprotein concentration following complete androgen blockage in men with prostatic carcinoma. Metabolism 36:244-250, 1987
36. Burstein M, Samaille J: Sur un dosage rapide du cholestérol lié aux β-lipoprotéines du sérum. Clin Chim Acta 5:609-610, 1960
37. Gidez LI, Miller GJ, Burstein M, et al: Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. J Lipid Res 23:1206-1223, 1982
38. Avogaro P, Bittolo Bon G, Cazzolato G, et al: Are apolipoproteins better discriminators than lipids for atherosclerosis? Lancet 1:901-903, 1979
39. Bittolo Bon G, Cazzolato G, Sccardi M, et al: Total plasma apo E and high density lipoprotein apo E in survivors of myocardial infarction. Atherosclerosis 53:69-75, 1984
40. Kwiterovich PO, Coresh J, Smith HH, et al: Comparison of the plasma levels of apolipoprotein B and apo A-I and other risk factors in men and women with premature coronary artery disease. Am J Cardiol 69:1015-1021, 1992
41. Genest JJ, Bard JM, Fruchart JC, et al: Plasma apolipoprotein A-I, A-II, B, E and C-III containing particles in men with premature coronary artery disease. Atherosclerosis 90:149-157, 1991
42. Meilhan EN, Kuller LH, Stein EA, et al: Characteristics associated with apoprotein and lipoprotein lipid levels in middle aged women. Arterioscler Thromb 8:515-520, 1988
43. Després JP, Moorjani S, Lupien PJ, et al: Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis 10:497-511, 1990
44. Laws A, Reaven GM: Evidence for an independent relationship between insulin resistance and fasting plasma HDL-cholesterol, triglyceride and insulin concentrations. J Intern Med 231:25-30, 1992
45. Laakso M, Sarlund H, Mykkanen L: Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance. Arterioscler Thromb 10:223-231, 1990
46. Patsch W, Sharett AR, Sorlic PD, et al: The relation of high density lipoprotein cholesterol and its subfractions to apolipoprotein A-I and fasting triglycerides: The role of environmental factors. The Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 136:546-557, 1992
47. Cremer P, Elster H, Labrot B, et al: Incidence ratio of fatal and unfatal myocardial infarction in relation to the lipoprotein profile: First prospective results from the Gottingen Risk, Incidence, and Prevalence Study (GRIPS). Klin Wochenschr 66:42-49, 1988 (suppl 11)
48. Salonen JT, Salonen R, Penttila I, et al: Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease. Am J Cardiol 56:226-231, 1985